NO and cGMP production has also been linked to release of calcium from rat lacrimal gland.
17 18 Jorgensen et al.
18 reported that inhibitors of guanylate cyclase and cGMP-dependent protein kinase Ia inhibits phenylephrine induced-Ca
2+ release. In addition, NO donors also stimulated release of Ca
2+ and NO meditated the release of Ca
2+ stimulated by β-adrenergic, but not α
1-adrenergic, agonists.
17 41 Addition of cGMP analogues did not increase [Ca
2+]
i, nor did they have any effect on cyclic ADP-ribose–induced Ca
2+ release, nor did α
1-adrenergic agonists increase NO production.
17 In these studies, NO was measured with the fluorescent molecule DAF-2. However, it is not possible to use the ratio method with DAF-2 as it is used with fura2.
41 Thus, its fluorescence is dependent on the amount of dye entering the cells, the extent of ester hydrolysis within the cell altering the nonfluorescent DAF-2 DA to the fluorescent DAF-2, and the number of cells in each preparation. These factors change with each cell preparation, making this method unreliable. In the present study, α
1-adrenergic agonists caused a significant increase in NO, as determined by reducing nitrate to nitrite and measuring the amount of nitrite using the Griess reaction, a well-established method. As studies have shown that α
1-adrenergic-agonist–induced protein secretion is dependent on an increase in [Ca
2+]
i,
12 it is possible that the synthesis of cGMP by NOS leads to an activation of guanylate cyclase followed by an increase in [Ca
2+]
i which ultimately leads to protein secretion. We did not examine the role of NO in the release of Ca
2+ in this study.